Entry |
|
Name |
Afuresertib (USAN/INN) |
Formula |
C18H17Cl2FN4OS
|
Exact mass |
426.0484
|
Mol weight |
427.32
|
Structure |
|
Simcomp |
|
Remark |
|
Efficacy |
Antineoplastic, AKT serine/threonine kinase inhibitor |
Comment |
Treatment of hematologic cancers
|
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
AGC group
AKT (PKB)
D10381 Afuresertib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 27
1 C8x C 10.9207 -14.7718
2 N5x N 10.9207 -16.1719
3 N4y N 12.2523 -16.6046
4 C8y C 13.0753 -15.4718
5 C8y C 12.2523 -14.3391
6 C8y C 14.4911 -15.4718
7 C8x C 15.3141 -16.6046
8 C8y C 16.6457 -16.1729
9 S2x S 16.6457 -14.7718
10 C8y C 15.3141 -14.3391
11 C5a C 17.8412 -16.9258
12 N1b N 19.0705 -16.2778
13 O5a O 17.8570 -18.3353
14 C1c C 20.2510 -17.0214
15 C1b C 21.4571 -16.3864
16 C8y C 22.6482 -17.1372
17 C8x C 22.6630 -18.5494
18 C8x C 23.7773 -19.2963
19 C8x C 25.0863 -18.6441
20 C8y C 25.0715 -17.2318
21 C8x C 23.8871 -16.4850
22 X F 26.3072 -16.5814
23 C1b C 20.1970 -18.4118
24 X Cl 12.6812 -13.0194
25 X Cl 14.8869 -13.0239
26 C1a C 12.6812 -17.9243
27 N1a N 21.4064 -19.1743
BOND 29
1 1 2 2
2 2 3 1
3 3 4 1
4 4 5 2
5 1 5 1
6 4 6 1
7 6 7 1
8 7 8 2
9 8 9 1
10 9 10 1
11 6 10 2
12 8 11 1
13 11 12 1
14 11 13 2
15 12 14 1
16 14 15 1
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 16 21 1
24 20 22 1
25 14 23 1 #Up
26 5 24 1
27 10 25 1
28 3 26 1
29 23 27 1
|